REFERENCES

• World Health Organization. Global burden of mental disorders and the need for a comprehensive, coordinated response from health and social sectors at the country level. Available at: http://apps.who.int/gb/ebwha/ pdf_files/EB130/B130_9-en.pdf. Updated December 1, 2011. Accessed January 7, 2014.
   Google Scholar
• MurroughJW.CharneyDS.Is there anything really novel on the antidepressant horizon?Curr Psychiatry Rep.20121464364922996298
   PubMed Web of Science ®Google Scholar
• DiMatteoMR.LepperHS.CroghanTW.Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.Arch intern Med.20001602101210710904452
   PubMed Web of Science ®Google Scholar
• Martins-de-SouzaD.Comprehending depression through proteomics.IntJ Neuropsychopharmacol.2012151373137422717368
   PubMed Web of Science ®Google Scholar
• WilkinsMR.PasqualiC.AppelRD.et alFrom proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis.Biotechnology (N Y).19961461659636313
   PubMedGoogle Scholar
• O'FarrellPH.High resolution two-dimensional electrophoresis of proteins.J Biol Chern.197525040074021
   PubMed Web of Science ®Google Scholar
• BjellqvistB.EkK.RighettiPG.et alIsoelectric focusing in immobilized pH gradients: principle, methodology and some applications.J Biochem Biophys Methods.198263173397142660
   PubMedGoogle Scholar
• GorgA.PostelW.GuntherS.et alApproach to stationary two-dimensional pattern: influence of focusing time and immobiline/carrier ampholytes concentrations.Electrophoresis.1988937462466646
   PubMed Web of Science ®Google Scholar
• HubnerNC.RenS.MannM.Peptide separation with immobilized pi strips is an attractive alternative to in-gel protein digestion for proteome analysis.Proteomics.200884862487219003865
   PubMed Web of Science ®Google Scholar
• WestermeierR.PostelW.WeserJ.GorgA.High-resolution two-dimensional electrophoresis with isoelectric focusing in immobilized pH gradients.J Biochem Biophys Methods.198383213306663005
   PubMedGoogle Scholar
• UnluM.MorganME.MindenJS.Difference gel electrophoresis: a single gel method for detecting changes in protein extracts.Electrophoresis.199718207120779420172
   PubMed Web of Science ®Google Scholar
• LinkAJ.EngJ.SchieltzDM.et alDirect analysis of protein complexes using mass spectrometry.Nat Biotechnol.19991767668210404161
   PubMed Web of Science ®Google Scholar
• FiliouMD.Martins-de-SouzaD.GuestPC.BahnS.TurckCW.To label or not to label: applications of quantitative proteomics in neuroscience research.Proteomics.20121273674722247077
   PubMed Web of Science ®Google Scholar
• GygiSP.RistB.GerberSA.TurecekF.GelbMH.AebersoldR.Quantitative analysis of complex protein mixtures using isotope-coded affinity tags.Nat Biotechnol.19991799499910504701
   PubMed Web of Science ®Google Scholar
• RossPL.HuangYN.MarcheseJN.et alMultiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents.Mol Cell Proteomics.200431154116915385600
   PubMed Web of Science ®Google Scholar
• OngSE.BlagoevB.KratchmarovaI.et alStable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics.Mol Cell Proteomics.2002137638612118079
   PubMed Web of Science ®Google Scholar
• Martins-de-SouzaD.GuestPC.Vanattou-SaifoudineN.HarrisLW.BahnS.Proteomic technologies for biomarker studies in psychiatry: advances and needs.Int Rev Neurobiol.2011101659422050849
   PubMed Web of Science ®Google Scholar
• Martins-de-SouzaD.GuestPC.RahmouneH.BahnS.Proteomic approaches to unravel the complexity of schizophrenia.Exp Rev Proteomics.2012997108
   PubMed Web of Science ®Google Scholar
• OliveiraBM.Martins-de-SouzaD.Large-scale analyses of schizophrenia proteome.Rev Psiq Clin.2013401619
   Google Scholar
• Martins-de-SouzaD.GuestPC.HarrisLW.et alIdentification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients.Transl Psychiatry.20122e8722832852
   PubMed Web of Science ®Google Scholar
• Kaidanovich-BeilinO.ChaDS.MclntyreRS.Crosstalk between metabolic and neuropsychiatric disorders.F1000 Biol Rep.201241422802875
   PubMedGoogle Scholar
• RezinGT.AmboniG.ZugnoAl.QuevedoJ.StreckEL.Mitochondrial dysfunction and psychiatric disorders.Neurochem Res.2009341021102918979198
   PubMed Web of Science ®Google Scholar
• StanleyJA.In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders.Can J Psychiatry.20024731532612025430
   PubMed Web of Science ®Google Scholar
• Martins-de-SouzaD.HarrisLW.GuestPC.BahnS.The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics.Antioxid Redox Signal.2011152067207920673161
   PubMed Web of Science ®Google Scholar
• FiliouMD.ZhangY.TeplytskaL.et alProteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways.Biol Psychiatry.2011701074108221791337
   PubMed Web of Science ®Google Scholar
• VaradarajuluJ.SchmittA.FalkaiP.AlsaifM.TurckCW.Martins-deSouzaD.Differential expression of HINT1 in schizophrenia brain tissue.Eur Arch Psychiatry Clin Neurosci.201226216717221553311
   PubMed Web of Science ®Google Scholar
• BarbierE.WangJB.Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level.BMC Neurosci.20091013219912621
   PubMed Web of Science ®Google Scholar
• VaradarajuluJ.LebarM.KrishnamoorthyG.et alIncreased anxietyrelated behaviour in HINT1 knockout mice.Behav Brain Res.201122030531121316396
   PubMed Web of Science ®Google Scholar
• Martins-de-SouzaD.GuestPC.Vanattou-SaifoudineN.RahmouneH.BahnS.Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function.Eur Arch Psychiatry Clin Neurosci.201226265766622350622
   PubMed Web of Science ®Google Scholar
• Johnston-WilsonNL.SimsCD.HofmannJP.et alDisease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium.Mol Psychiatry.2000514214910822341
   PubMed Web of Science ®Google Scholar
• BeasleyCL.PenningtonK.BehanA.WaitR.DunnMJ.CotterD.Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes.Proteomics.200663414342516637010
   PubMed Web of Science ®Google Scholar
• HensleyK.VenkovaK.ChristovA.GunningW.ParkJ.Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications.Mol Neurobiol.20114318019121271304
   PubMed Web of Science ®Google Scholar
• HuangJT.LewekeFM.OxleyD.et alDisease biomarkers in cerebrospinal fluid of patients with first-onset psychosis.PLoS Med.20063e42817090210
   PubMed Web of Science ®Google Scholar
• DitzenC.TangN.JastorffAM.et alCerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology.Neuropsychopharmacology.2012371013102522169944
   PubMed Web of Science ®Google Scholar
• Martins-De-SouzaD.WobrockT.ZerrI.et alDifferent apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls.World J Biol Psychiatry.20101171972820446881
   PubMed Web of Science ®Google Scholar
• CarboniL.BecchiS.PiubelliC.et alEarly-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression.Prog Neuropsychopharmacoi Biol Psychiatry.20103410371048
   PubMed Web of Science ®Google Scholar
• ZhangY.FiliouMD.ReckowS.et alProteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways.Mol Cell Proteomics.201110M111.008110
   PubMed Web of Science ®Google Scholar
• XuHB.ZhangRF.LuoD.et alComparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation.Int J Neuropsychopharmacol.2012151413142522717272
   PubMed Web of Science ®Google Scholar
• Martins-de-SouzaD.Is the word' biomarker' being properly used by proteomics research in neuroscience?Eur Arch Psychiatry Clin Neurosci.201026056156220155362
   PubMed Web of Science ®Google Scholar
• Martins-de-SouzaD.MaccarroneG.IsingM.et alBlood mononuclear cell proteome suggests Integrin and Ras signaling as critical pathways for antidepressant treatment response.Biol Psychiatry. 2014. In press.
   Google Scholar
• RaamsdonkLM.TeusinkB.BroadhurstD.et alA functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations.Nat Biotechnol.200119455011135551
   PubMed Web of Science ®Google Scholar
• NicholsonJK.LindonJC.HolmesE.'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.Xenobiotica.1999291181118910598751
   PubMed Web of Science ®Google Scholar
• Kaddurah-DaoukR.KrishnanKR.Metabolomics: a global biochemical approach to the study of central nervous system diseases.Neuropsychopharmacology.20093417318618843269
   PubMed Web of Science ®Google Scholar
• ShinMH.Lee doY.LiuKH.FiehnO.KimKH.Evaluation of sampling and extraction methodologies for the global metabolic profiling of Saccharophagus degradans.Anal Chem.2010826660666620669998
   PubMed Web of Science ®Google Scholar
• CubbonS.AntonioC.WilsonJ.Thomas-OatesJ.Metabolomic applications of HILIC-LC-MS.Mass Spectrom Rev.20102967168419557839
   PubMed Web of Science ®Google Scholar
• RojoD.BarbasC.RuperezFJ.LC-MS metabolomics of polar compounds.Bioanalysis.201241235124322651567
   PubMed Web of Science ®Google Scholar
• NemutluE.ZhangS.JuranicNO.TerzicA.MacuraS.DzejaP.180-assisted dynamic metabolomics for individualized diagnostics and treatment of human diseases.Croat Med J.20125352953423275318
   PubMed Web of Science ®Google Scholar
• SmolinskaA.BlanchetL.BuydensLM.WijmengaSS.NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review.Anal Chim Acta.2012750829723062430
   PubMed Web of Science ®Google Scholar
• ReoNV.NMR-based metabolomics.Drug Chem Toxicol.20022537538212378948
   PubMed Web of Science ®Google Scholar
• HaradaK.FukusakiE.BambaT.SatoF.KobayashiA.In vivo 15N-enrichment of metabolites in suspension cultured cells and its application to metabolomics.Biotechnol Prog.2006221003101116889377
   PubMed Web of Science ®Google Scholar
• ZamboniN.SauerU.Novel biological insights through metabolomics and 13C-flux analysis.Curr Opin Microbiol.20091255355819744879
   PubMed Web of Science ®Google Scholar
• BeckerS.KortzL.HelmschrodtC.ThieryJ.CeglarekU.LC-MS-based metabolom ics in the clinical laboratory.J Chromatogr B Analyt Technol Biomed LifeSci.2012883-8846875
   PubMed Web of Science ®Google Scholar
• DettmerK.AronovPA.HammockBD.Mass spectrometry-based metabolomics.Mass Spectrom Rev.200726517816921475
   PubMed Web of Science ®Google Scholar
• MilneSB.MathewsTP.MyersDS.IvanovaPT.BrownHA.Sum of the parts: mass spectrometry-based metabolomics.Biochemistry.2013523829384023442130
   PubMed Web of Science ®Google Scholar
• GarciaA.BarbasC.Gas chromatography-mass spectrometry (GC-MS)based metabolomics.Methods Mol Biol.201170819120421207291
   PubMedGoogle Scholar
• ZhouB.XiaoJF.TuliL.RessomHW.LC-MS-based metabolomics.Mol Biosyst.2012847048122041788
   PubMed Web of Science ®Google Scholar
• RamautarR.SomsenGW.de JongGJ.CE-MS for metabolomics: developments and applications in the period 2010-2012.Electrophoresis.201334869823161106
   PubMed Web of Science ®Google Scholar
• LeiZ.HuhmanDV.SumnerLW.Mass spectrometry strategies in metabolomics.J Biol Chem.2011286254352544221632543
   PubMed Web of Science ®Google Scholar
• DaiY.LiZ.XueL.et alMetabolomics study on the anti-depression effect of xiaoyaosan on rat model of chronic unpredictable mild stress.J Ethnopharmacol.201012848248920079416
   PubMed Web of Science ®Google Scholar
• ZhengS.YuM.LuX.et alUrinary metabonomic study on biochemical changes in chronic unpredictable mild stress model of depression.Clin Chim Acta.201041120420919913000
   PubMed Web of Science ®Google Scholar
• ZhangF.JiaZ.GaoP.et alMetabonomics study of urine and plasma in depression and excess fatigue rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry.Mol Biosyst.2010685286120567771
   PubMedGoogle Scholar
• WangX.ZengC.LinJ.et alMetabonomics approach to assessing the modulatory effects of St John's wort, ginsenosides, and clomipramine in experimental depression.J Proteome Res.2012116223623023110693
   PubMed Web of Science ®Google Scholar
• Kaddurah-DaoukR.YuanP.BoyleSH.et alCerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile.Sci Rep.2012266722993692
   PubMed Web of Science ®Google Scholar
• PaigeLA.MitchellMW.KrishnanKR.Kaddurah-DaoukR.SteffensDC.A preliminary metabolomic analysis of older adults with and without depression.Int J Geriatr Psychiatry.20072241842317048218
   PubMed Web of Science ®Google Scholar
• SteffensDC.WeiJ.KrishnanKR.et alMetabolomic differences in heart failure patients with and without major depression.J Geriatr Psychiatry Neurol.20102313814620101071
   PubMed Web of Science ®Google Scholar
• ZhengP.GaoHC.LiQ.et alPlasma metabonomics as a novel diagnostic approach for major depressive disorder.J Proteome Res.2012111741174822239730
   PubMed Web of Science ®Google Scholar
• ZhengP.WangY.ChenL.et alIdentification and validation of urinary metabolite biomarkers for major depressive disorder.Mol Cell Proteomics.20131220721423111923
   PubMed Web of Science ®Google Scholar
• Kaddurah-DaoukR.BoyleSH.MatsonW.et alPretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.Transl Psychiatry.20111.piie26
   Web of Science ®Google Scholar
• Kaddurah-DaoukR.BogdanovMB.WikoffWR.et alPharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo.Transl Psychiatry.20133e22323340506
   PubMed Web of Science ®Google Scholar
• Martins-de-SouzaD.Translational strategies to schizophrenia from a proteomic perspective.Transl Neurosci.20123300302
   Web of Science ®Google Scholar
• CoulombeB.Mapping the disease protein interactome: toward a molecular medicine GPS to accelerate drug and biomarker discovery.J Proteome Res.20111012012520939596
   PubMed Web of Science ®Google Scholar
• WilliamsonMP.SutcllffeMJ.Protein-protein interactions.Biochem Soc Trans.20103887587820658969
   PubMed Web of Science ®Google Scholar
• ChenJ.ZhouJ.SandersCK.NolanJP.CaiH.A surface display yeast twohybrid screening system for high-throughput protein interactome mapping.Anal Biochem.2009390293719298787
   PubMed Web of Science ®Google Scholar
• ScifoE.SzwajdaA.DebskiJ.et alDrafting the CLN3 protein interactome in SH-SY5Y human neuroblastoma cells: a label-free quantitative proteomics approach.J Proteome Res.2013122101211523464991
   PubMed Web of Science ®Google Scholar
• Van LeeneJ.StalsH.EeckhoutD.et alA tandem affinity purificationbased technology platform to study the cell cycle interactome in Arabidopsis thaliana.Mol Cell Proteomics.200761226123817426018
   PubMed Web of Science ®Google Scholar
• MarkhamK.BaiY.Schmitt-UlmsG.Co-immunoprecipitations revisited: an update on experimental concepts and their implementation for sensitive interactome investigations of endogenous proteins.Anal Bioanal Chem.200738946147317583802
   PubMed Web of Science ®Google Scholar
• BonfiglioJJ.MaccarroneG.RewertsC.et alCharacterization of the B-Raf interactome in mouse hippocampal neuronal cells.J Proteomics.20117418619821055488
   PubMed Web of Science ®Google Scholar
• NikolskyY.NikolskayaT.BugrimA.Biological networks and analysis of experimental data in drug discovery.Drug Discov Today.20051065366215894230
   PubMed Web of Science ®Google Scholar
• SteinA.MoscaR.AloyP.Three-dimensional modeling of protein interactions and complexes is going'omics.Curr Opin Struct Biol.20112120020821320770
   PubMed Web of Science ®Google Scholar
• ValenciaA.PazosF.Computational methods for the prediction of protein interactions.Curr Opin Struct Biol.20021236837312127457
   PubMed Web of Science ®Google Scholar
• WeichhartT.SaemannMD.The P13K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications.Ann Rheum Dis.200867(suppl 3)iii707419022819
   PubMed Web of Science ®Google Scholar
• Pilot-StorckF.ChopinE.RualJF.et alInteractome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor.Mol Cell Proteomics.201091578159320368287
   PubMed Web of Science ®Google Scholar
• JiaP.KaoCF.KuoPH.ZhaoZ.A comprehensive network and pathway analysis of candidate genes in major depressive disorder.BMC Syst Biol.20115 Suppl 3S1222784618
   PubMed Web of Science ®Google Scholar
• Sperner-UnterwegerB.KohlC.FuchsD.Immune changes and neurotransmitters: Possible interactions in depression?Prog Neuropsychopharmacol Biol Psychiatry.20144826827623085509
   PubMed Web of Science ®Google Scholar
• Martins-de-SouzaD.Proteomics is not only a biomarker discovery tool.Proteomics Clin Appl.2009311361139
   Web of Science ®Google Scholar
• FranceschiniA.SzklarczykD.FrankildS.et alSTRING v9.1: protein-protein interaction networks, with increased coverage and integration.Nucleic Acids Res.201341 (Database issue)D80881523203871
   PubMed Web of Science ®Google Scholar
• SmootME.OnoK.RuscheinskiJ.WangPL.IdekerT.Cytoscape 2.8: new features for data integration and network visualization.Bioinformatics.20112743143221149340
   PubMed Web of Science ®Google Scholar
• SchrattenholzA.GroebeK.SoskicV.Systems biology approaches and tools for analysis of interactomes and multi-target drugs.Methods Mol Biol.2010662295820824465
   PubMedGoogle Scholar
• TurckCW.IrisF.Proteome-based pathway modelling of psychiatric disorders.Pharmacopsychiatry.201144 (suppl 1)55461
   Web of Science ®Google Scholar
• FiliouMD.TurckCW.Martins-de-SouzaD.Quantitative proteomics for investigating psychiatric disorders.Proteomics Clin Appl.20115384921280236
   PubMed Web of Science ®Google Scholar
• GormannsP.MuellerNS.DitzenC.WolfS.HolsboerF.TurckCW.Phenome-transcriptome correlation unravels anxiety and depression related pathways.J Psychiatr Res.20114597397921255794
   PubMed Web of Science ®Google Scholar
• YangY.YangD.TangG.et alProteomics reveals energy and glutathione metabolic dysregulation in the prefrontal cortex of a rat model of depression.Neuroscience.201324719120023727007
   PubMed Web of Science ®Google Scholar
• BisgaardCF.BakS.ChristensenT.JensenON.EnghildJJ.WiborgO.Vesicular signalling and immune modulation as hedonic fingerprints: proteomic profiling in the chronic mild stress depression model.J Psychopharmacol.2012261569158323139383
   PubMed Web of Science ®Google Scholar
• XuZ.HouB.ZhangY.et alAntidepressive behaviors induced byenriched environment might be modulated by glucocorticoid levels.Eur Neuropsychopharmacoi.200919868875
   PubMed Web of Science ®Google Scholar
• CarboniL.Peripheral biomarkers in animal models of major depressive disorder.Dis Markers.2013358
   Google Scholar
• ConnollyKR.ThaseME.Emerging drugs for major depressive disorder.Expert Opin Emerg Drugs.20121710512622339643
   PubMed Web of Science ®Google Scholar
• Martins-de-SouzaD.Biomarkers for psychiatric disorders: where are we standing?Dis Markers.2013351224167343
   PubMed Web of Science ®Google Scholar
• DomeniciE.WilleDR.TozziF.et alPlasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections.PLoS One.20105e916620161799
   PubMed Web of Science ®Google Scholar
• RaedlerTJ.WiedemannK.CSF-studies in neuropsychiatric disorders.Neuro Endocrinol Lett.20062729730516807525
   PubMed Web of Science ®Google Scholar
• BahnS.SchwarzE.HarrisLW.Martins-de-SouzaD.RahmouneH.GuestPC.Biomarker blood tests for diagnosis and management of mental disorders: focus on schizophrenia.Rev Psiq Clin.2013407
   Google Scholar